Recent progress in the study of the Rheb family GTPases
Copyright © 2014 Elsevier Inc. All rights reserved..
In this review we highlight recent progress in the study of Rheb family GTPases. Structural studies using X-ray crystallography and NMR have given us insight into unique features of this GTPase. Combined with mutagenesis studies, these works have expanded our understanding of residues that affect Rheb GTP/GDP bound ratios, effector protein interactions, and stimulation of mTORC1 signaling. Analysis of cancer genome databases has revealed that several human carcinomas contain activating mutations of the protein. Rheb's role in activating mTORC1 signaling at the lysosome in response to stimuli has been further elucidated. Rheb has also been suggested to play roles in other cellular pathways including mitophagy and peroxisomal ROS response. A number of studies in mice have demonstrated the importance of Rheb in development, as well as in a variety of functions including cardiac protection and myelination. We conclude with a discussion of future prospects in the study of Rheb family GTPases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Cellular signalling - 26(2014), 9 vom: 18. Sept., Seite 1950-7 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Heard, Jeffrey J [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 03.03.2015 Date Revised 03.12.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.cellsig.2014.05.011 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM238584569 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM238584569 | ||
003 | DE-627 | ||
005 | 20231224114119.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.cellsig.2014.05.011 |2 doi | |
028 | 5 | 2 | |a pubmed24n0795.xml |
035 | |a (DE-627)NLM238584569 | ||
035 | |a (NLM)24863881 | ||
035 | |a (PII)S0898-6568(14)00181-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Heard, Jeffrey J |e verfasserin |4 aut | |
245 | 1 | 0 | |a Recent progress in the study of the Rheb family GTPases |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.03.2015 | ||
500 | |a Date Revised 03.12.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2014 Elsevier Inc. All rights reserved. | ||
520 | |a In this review we highlight recent progress in the study of Rheb family GTPases. Structural studies using X-ray crystallography and NMR have given us insight into unique features of this GTPase. Combined with mutagenesis studies, these works have expanded our understanding of residues that affect Rheb GTP/GDP bound ratios, effector protein interactions, and stimulation of mTORC1 signaling. Analysis of cancer genome databases has revealed that several human carcinomas contain activating mutations of the protein. Rheb's role in activating mTORC1 signaling at the lysosome in response to stimuli has been further elucidated. Rheb has also been suggested to play roles in other cellular pathways including mitophagy and peroxisomal ROS response. A number of studies in mice have demonstrated the importance of Rheb in development, as well as in a variety of functions including cardiac protection and myelination. We conclude with a discussion of future prospects in the study of Rheb family GTPases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Review | |
650 | 4 | |a Lysosome | |
650 | 4 | |a Mouse study | |
650 | 4 | |a Mutants | |
650 | 4 | |a Rheb GTPase | |
650 | 4 | |a Structure | |
650 | 4 | |a mTORC1 | |
650 | 7 | |a Multiprotein Complexes |2 NLM | |
650 | 7 | |a Mechanistic Target of Rapamycin Complex 1 |2 NLM | |
650 | 7 | |a EC 2.7.11.1 |2 NLM | |
650 | 7 | |a TOR Serine-Threonine Kinases |2 NLM | |
650 | 7 | |a EC 2.7.11.1 |2 NLM | |
650 | 7 | |a Monomeric GTP-Binding Proteins |2 NLM | |
650 | 7 | |a EC 3.6.5.2 |2 NLM | |
700 | 1 | |a Fong, Valerie |e verfasserin |4 aut | |
700 | 1 | |a Bathaie, S Zahra |e verfasserin |4 aut | |
700 | 1 | |a Tamanoi, Fuyuhiko |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cellular signalling |d 1993 |g 26(2014), 9 vom: 18. Sept., Seite 1950-7 |w (DE-627)NLM012637653 |x 1873-3913 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2014 |g number:9 |g day:18 |g month:09 |g pages:1950-7 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cellsig.2014.05.011 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2014 |e 9 |b 18 |c 09 |h 1950-7 |